Publication | Closed Access

Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy

NanoparticlesNanomedicineCell-based Drug DeliveryPromising SimpleEngineeringMedicineNano-drug DeliveryNeurologyBiomedical EngineeringNeuroscienceMultiple SclerosisIntranasal DeliveryNeuroimmunologyNeuroinflammation